RMED VS MRAI Stock Comparison

Performance

RMED
10/100

RMED returned -95.79% in the last 12 months. Based on SPY's performance of -8.73%, its performance is below average giving it a score of 10 of 100.

MRAI
10/100

MRAI returned -82.78% in the last 12 months. Based on SPY's performance of -13.77%, its performance is below average giving it a score of 10 of 100.

Analyst Price Targets

RMED
75/100

4 analysts offer 12-month price targets for RMED. Together, they have an average target of 0, the most optimistic target put RMED at 0 within 12-months and the most pessimistic has RMED at 0. These analyst ratings are from our partners at Financial Modeling Prep and Alpha Vantage.

MRAI

"Analyst Price Targets" not found for MRAI

Technicals

RMED
11/100

RMED receives a 10 of 100 based on 14 indicators. 1 are bullish, 12 are bearish.

MRAI
57/100

MRAI receives a 57 of 100 based on 14 indicators. 7 are bullish, 5 are bearish.

Earnings

RMED
10/100

RMED has missed earnings 12 times in the last 20 quarters.

MRAI
10/100

MRAI has missed earnings 5 times in the last 20 quarters.

Profit

RMED
10/100

Out of the last 20 quarters, RMED has had 0 profitable quarters and has increased their profits year over year on 0 of them.

MRAI
10/100

Out of the last 13 quarters, MRAI has had 0 profitable quarters and has increased their profits year over year on 1 of them.

Volatility

RMED
44/100

RMED has had a lower than average amount of volatility over the last 12 months giving it a score of 44 of 100.

MRAI
46/100

MRAI has had a lower than average amount of volatility over the last 12 months giving it a score of 46 of 100.

Sentiment

RMED

"Sentiment" not found for RMED

MRAI
70/100

MRAI had a bullish sentiment score of 70.34% across Twitter and StockTwits over the last 12 months. It had an average of 30.42 posts, 6.28 comments, and 37.26 likes per day.

All score calculations are broken down here to help you make more informed investing decisions

Ra Medical Systems, Inc Summary

Healthcare

Medical Devices

Ra Medical Systems, Inc., a medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular immune-mediated inflammatory diseases. It offers destruction of arteriosclerotic blockages by laser radiation ablation, a minimally invasive excimer laser and single-use catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. The company sells its products primarily through distributors in the United States. Ra Medical Systems, Inc. was incorporated in 2002 and is headquartered in Carlsbad, California.

Marpai, Inc. Class A Common Stock Summary

Nasdaq / MRAI

Healthcare

Medical - Healthcare Plans

Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, health savings account administration, and cost containment services. It also develops artificial intelligence and healthcare technology that enables the analysis of data to predict and prevent events related to diagnostic errors, hospital visits, and administrative issues. The company was incorporated in 2021 and is headquartered in New York, New York.

Power up your portfolio